vs
N-able, Inc.（NABL）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
N-able, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.7倍（$130.3M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 11.8%），N-able, Inc.自由现金流更多（$20.9M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 7.0%）
Able UK是一家英国工业服务企业，主打船舶与海上设施的退役拆解业务，深耕该领域多年，具备大型工业设施拆除作业的专业能力与丰富经验，在英国相关工业服务市场占据一席之地。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NABL vs PBYI — 直观对比
营收规模更大
NABL
是对方的1.7倍
$75.5M
营收增速更快
PBYI
高出15.9%
11.8%
自由现金流更多
NABL
多$6.5M
$14.4M
两年增速更快
PBYI
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $130.3M | $75.5M |
| 净利润 | — | — |
| 毛利率 | 76.2% | 69.3% |
| 营业利润率 | 10.2% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 11.8% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.04 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NABLPBYI
| Q4 25 | $130.3M | $75.5M | ||
| Q3 25 | $131.7M | $54.5M | ||
| Q2 25 | $131.2M | $52.4M | ||
| Q1 25 | $118.2M | $46.0M | ||
| Q4 24 | $116.5M | $59.1M | ||
| Q3 24 | $116.4M | $80.5M | ||
| Q2 24 | $119.4M | $47.1M | ||
| Q1 24 | $113.7M | $43.8M |
净利润NABLPBYI
| Q4 25 | — | — | ||
| Q3 25 | $1.4M | $8.8M | ||
| Q2 25 | $-4.0M | $5.9M | ||
| Q1 25 | $-7.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $10.8M | $20.3M | ||
| Q2 24 | $9.5M | $-4.5M | ||
| Q1 24 | $7.5M | $-4.8M |
毛利率NABLPBYI
| Q4 25 | 76.2% | 69.3% | ||
| Q3 25 | 77.5% | 77.7% | ||
| Q2 25 | 78.1% | 76.5% | ||
| Q1 25 | 76.6% | 77.1% | ||
| Q4 24 | 80.0% | 76.4% | ||
| Q3 24 | 82.9% | 63.9% | ||
| Q2 24 | 84.0% | 77.4% | ||
| Q1 24 | 83.9% | 75.5% |
营业利润率NABLPBYI
| Q4 25 | 10.2% | 22.7% | ||
| Q3 25 | 8.8% | 17.6% | ||
| Q2 25 | 7.7% | 12.7% | ||
| Q1 25 | 1.5% | 8.7% | ||
| Q4 24 | 13.7% | 22.6% | ||
| Q3 24 | 20.5% | 27.4% | ||
| Q2 24 | 18.4% | -4.6% | ||
| Q1 24 | 18.0% | -5.3% |
净利率NABLPBYI
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | 16.2% | ||
| Q2 25 | -3.1% | 11.2% | ||
| Q1 25 | -6.1% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.2% | 25.2% | ||
| Q2 24 | 7.9% | -9.6% | ||
| Q1 24 | 6.6% | -11.0% |
每股收益（稀释后）NABLPBYI
| Q4 25 | $-0.04 | $0.26 | ||
| Q3 25 | $0.01 | $0.17 | ||
| Q2 25 | $-0.02 | $0.12 | ||
| Q1 25 | $-0.04 | $0.06 | ||
| Q4 24 | $0.01 | $0.40 | ||
| Q3 24 | $0.06 | $0.41 | ||
| Q2 24 | $0.05 | $-0.09 | ||
| Q1 24 | $0.04 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $111.8M | $97.5M |
| 总债务越低越好 | $393.9M | $22.7M |
| 股东权益账面价值 | $804.7M | $130.3M |
| 总资产 | $1.4B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.49× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NABLPBYI
| Q4 25 | $111.8M | $97.5M | ||
| Q3 25 | $101.4M | $94.4M | ||
| Q2 25 | $93.9M | $96.0M | ||
| Q1 25 | $94.1M | $93.2M | ||
| Q4 24 | $85.2M | $101.0M | ||
| Q3 24 | $174.4M | $96.7M | ||
| Q2 24 | $157.5M | $96.8M | ||
| Q1 24 | $139.2M | $107.2M |
总债务NABLPBYI
| Q4 25 | $393.9M | $22.7M | ||
| Q3 25 | $331.7M | $34.0M | ||
| Q2 25 | $332.1M | $45.3M | ||
| Q1 25 | $332.6M | $56.7M | ||
| Q4 24 | $333.1M | $68.0M | ||
| Q3 24 | $333.6M | $79.3M | ||
| Q2 24 | $334.1M | $90.7M | ||
| Q1 24 | $334.5M | $102.0M |
股东权益NABLPBYI
| Q4 25 | $804.7M | $130.3M | ||
| Q3 25 | $813.4M | $115.3M | ||
| Q2 25 | $809.4M | $104.7M | ||
| Q1 25 | $775.1M | $97.1M | ||
| Q4 24 | $759.3M | $92.1M | ||
| Q3 24 | $765.0M | $71.1M | ||
| Q2 24 | $724.4M | $48.5M | ||
| Q1 24 | $709.1M | $51.0M |
总资产NABLPBYI
| Q4 25 | $1.4B | $216.3M | ||
| Q3 25 | $1.4B | $202.9M | ||
| Q2 25 | $1.4B | $194.9M | ||
| Q1 25 | $1.4B | $196.2M | ||
| Q4 24 | $1.3B | $213.3M | ||
| Q3 24 | $1.2B | $220.7M | ||
| Q2 24 | $1.2B | $205.0M | ||
| Q1 24 | $1.1B | $214.1M |
负债/权益比NABLPBYI
| Q4 25 | 0.49× | 0.17× | ||
| Q3 25 | 0.41× | 0.30× | ||
| Q2 25 | 0.41× | 0.43× | ||
| Q1 25 | 0.43× | 0.58× | ||
| Q4 24 | 0.44× | 0.74× | ||
| Q3 24 | 0.44× | 1.12× | ||
| Q2 24 | 0.46× | 1.87× | ||
| Q1 24 | 0.47× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $20.9M | $14.4M |
| 自由现金流率自由现金流/营收 | 16.0% | 19.1% |
| 资本支出强度资本支出/营收 | 3.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $75.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流NABLPBYI
| Q4 25 | $25.3M | $14.4M | ||
| Q3 25 | $24.0M | $9.7M | ||
| Q2 25 | $24.2M | $14.1M | ||
| Q1 25 | $19.7M | $3.6M | ||
| Q4 24 | $26.0M | $15.6M | ||
| Q3 24 | $22.0M | $11.0M | ||
| Q2 24 | $27.3M | $1.0M | ||
| Q1 24 | $4.2M | $11.2M |
自由现金流NABLPBYI
| Q4 25 | $20.9M | $14.4M | ||
| Q3 25 | $17.4M | $9.7M | ||
| Q2 25 | $20.4M | $14.1M | ||
| Q1 25 | $16.4M | $3.6M | ||
| Q4 24 | $18.8M | $15.6M | ||
| Q3 24 | $18.2M | $11.0M | ||
| Q2 24 | $24.0M | $1.0M | ||
| Q1 24 | $746.0K | — |
自由现金流率NABLPBYI
| Q4 25 | 16.0% | 19.1% | ||
| Q3 25 | 13.2% | 17.7% | ||
| Q2 25 | 15.5% | 26.8% | ||
| Q1 25 | 13.9% | 7.7% | ||
| Q4 24 | 16.2% | 26.4% | ||
| Q3 24 | 15.7% | 13.7% | ||
| Q2 24 | 20.1% | 2.1% | ||
| Q1 24 | 0.7% | — |
资本支出强度NABLPBYI
| Q4 25 | 3.4% | 0.0% | ||
| Q3 25 | 5.0% | 0.0% | ||
| Q2 25 | 2.9% | 0.0% | ||
| Q1 25 | 2.8% | 0.1% | ||
| Q4 24 | 6.1% | 0.0% | ||
| Q3 24 | 3.2% | 0.0% | ||
| Q2 24 | 2.7% | 0.0% | ||
| Q1 24 | 3.0% | 0.0% |
现金转化率NABLPBYI
| Q4 25 | — | — | ||
| Q3 25 | 17.36× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.04× | 0.54× | ||
| Q2 24 | 2.89× | — | ||
| Q1 24 | 0.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NABL
| Transferred Over Time | $121.9M | 94% |
| Transferred At Point In Time | $8.4M | 6% |
| Other Revenue | $1.3M | 1% |
PBYI
暂无分部数据
